Simple Summary Surgery is generally the treatment of choice for locoregional recurrences of
well-differentiated thyroid carcinomas, but other therapies can be considered on an …

Although most patients with differentiated thyroid cancer (DTC) of follicular cell origin enjoy a
relatively good prognosis, some patients unfortunately present with or develop locally …

Background Differentiated thyroid cancer (DTC) survival is excellent, making recurrence a
more clinically relevant prognosticator. We hypothesized that the new American Joint …

Background: Retropharyngeal lymph node metastases (RPMs) from differentiated thyroid
carcinoma (DTC) are rare. Treatment includes surgical resection, radioactive iodine (RAI) …

Though survival for well-differentiated thyroid cancer is very good, specific populations suffer
greater recurrence and mortality. Defining these cohorts can significantly influence …

Thyroid cancer is the most common endocrine malignancy, although representing fewer
than 1% of all human tumors. Differentiated thyroid carcinoma (DTC) includes the papillary …

The demography of differentiated thyroid cancers (DTCs) has changed considerably since
the 1990s, when the vast majority of these tumors were clinically evident at the time of …

Risk adapted treatment recommendations are dependent on accurate predictions of the risk
of recurrence, risk of death, and likely sites of recurrence. When combined with response to …

Background. The role of operations for distantly metastatic well-differentiated thyroid
carcinoma (DTC) is poorly defined. We review the indications for operation for metastatic …

Differentiated thyroid carcinoma (DTC) is usually an indolent tumor associated with a low
mortality. However, DTC, particularly papillary thyroid carcinoma, happens to be a …